| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | sarcolemma | 8.09e-05 | 190 | 153 | 8 | GO:0042383 | |
| GeneOntologyCellularComponent | basal plasma membrane | INPPL1 TLR9 ABCC6 SLC22A7 SLC4A1 GPIHBP1 SLCO1C1 SLC16A1 C5AR1 SLC26A11 | 2.88e-04 | 354 | 153 | 10 | GO:0009925 |
| GeneOntologyCellularComponent | basal part of cell | INPPL1 TLR9 ABCC6 SLC22A7 SLC4A1 GPIHBP1 SLCO1C1 SLC16A1 C5AR1 SLC26A11 | 4.83e-04 | 378 | 153 | 10 | GO:0045178 |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 4.89e-04 | 50 | 153 | 4 | GO:0098878 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | TLR9 ABCC6 SLC22A7 SLC4A1 GPIHBP1 SLCO1C1 SLC16A1 C5AR1 SLC26A11 | 5.99e-04 | 320 | 153 | 9 | GO:0016323 |
| Domain | PAX | 2.00e-11 | 9 | 150 | 6 | SM00351 | |
| Domain | PAIRED_2 | 2.00e-11 | 9 | 150 | 6 | PS51057 | |
| Domain | PAIRED_1 | 2.00e-11 | 9 | 150 | 6 | PS00034 | |
| Domain | Paired_dom | 2.00e-11 | 9 | 150 | 6 | IPR001523 | |
| Domain | PAX | 2.00e-11 | 9 | 150 | 6 | PF00292 | |
| Domain | Pax7_C | 6.41e-05 | 2 | 150 | 2 | IPR022106 | |
| Domain | Pax7 | 6.41e-05 | 2 | 150 | 2 | PF12360 | |
| Domain | Pax2_C | 1.91e-04 | 3 | 150 | 2 | IPR022130 | |
| Domain | Pax2_C | 1.91e-04 | 3 | 150 | 2 | PF12403 | |
| Domain | Abhydrolase_2 | 1.91e-04 | 3 | 150 | 2 | PF02230 | |
| Domain | PLipase/COase/thioEstase | 1.91e-04 | 3 | 150 | 2 | IPR003140 | |
| Domain | FacI_MAC | 3.80e-04 | 4 | 150 | 2 | IPR003884 | |
| Domain | FIMAC | 3.80e-04 | 4 | 150 | 2 | SM00057 | |
| Domain | TMEM132D_N | 6.31e-04 | 5 | 150 | 2 | PF15705 | |
| Domain | TMEM132D_C | 6.31e-04 | 5 | 150 | 2 | PF15706 | |
| Domain | TMEM132_M | 6.31e-04 | 5 | 150 | 2 | IPR031437 | |
| Domain | TMEM132_C | 6.31e-04 | 5 | 150 | 2 | IPR031436 | |
| Domain | TMEM132_N | 6.31e-04 | 5 | 150 | 2 | IPR031435 | |
| Domain | TMEM132 | 6.31e-04 | 5 | 150 | 2 | IPR026307 | |
| Domain | TMEM132 | 6.31e-04 | 5 | 150 | 2 | PF16070 | |
| Pubmed | 6.64e-13 | 9 | 158 | 6 | 7883790 | ||
| Pubmed | 6.64e-13 | 9 | 158 | 6 | 10197584 | ||
| Pubmed | Chromosomal localization of seven PAX genes and cloning of a novel family member, PAX-9. | 6.64e-13 | 9 | 158 | 6 | 7981748 | |
| Pubmed | Pax3 Hypomorphs Reveal Hidden Pax7 Functional Genetic Compensation in Utero. | 3.62e-12 | 11 | 158 | 6 | 35645295 | |
| Pubmed | Pax: a murine multigene family of paired box-containing genes. | 5.26e-09 | 15 | 158 | 5 | 1685142 | |
| Pubmed | Roles of Pax-genes in developing and adult brain as suggested by expression patterns. | 6.11e-09 | 6 | 158 | 4 | 8126546 | |
| Pubmed | 6.11e-09 | 6 | 158 | 4 | 1485966 | ||
| Pubmed | 5.08e-08 | 9 | 158 | 4 | 15520281 | ||
| Pubmed | Requirement of the paraxis gene for somite formation and musculoskeletal patterning. | 8.43e-08 | 10 | 158 | 4 | 8955271 | |
| Pubmed | Conservation of the paired domain in metazoans and its structure in three isolated human genes. | 9.20e-08 | 3 | 158 | 3 | 2501086 | |
| Pubmed | 9.20e-08 | 3 | 158 | 3 | 1974085 | ||
| Pubmed | Homeobox genes: a link between development, cell cycle, and cancer? | 1.32e-07 | 11 | 158 | 4 | 10328847 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ALKBH4 MAN2A2 INPPL1 THAP8 MLLT10 REV3L FHIP1B KIFC2 EML3 FASN C2CD3 CELSR3 KCNJ11 STRN4 PCNX1 PAX2 BRAT1 DOCK6 AGRN EP300 | 1.61e-07 | 1105 | 158 | 20 | 35748872 |
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 9297966 | ||
| Pubmed | Maternal transmission effects of the PAX genes among cleft case-parent trios from four populations. | 3.67e-07 | 4 | 158 | 3 | 19142206 | |
| Pubmed | 5.38e-07 | 15 | 158 | 4 | 12925591 | ||
| Pubmed | Transcription factors Mesp2 and Paraxis have critical roles in axial musculoskeletal formation. | 7.15e-07 | 16 | 158 | 4 | 17477400 | |
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 8099544 | ||
| Pubmed | 1.51e-06 | 19 | 158 | 4 | 8575294 | ||
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 10364424 | ||
| Pubmed | Deletion of Pax1 scoliosis-associated regulatory elements leads to a female-biased tail abnormality. | 1.82e-06 | 6 | 158 | 3 | 38461417 | |
| Pubmed | Mapping of the human homologs of the murine paired-box-containing genes. | 1.82e-06 | 6 | 158 | 3 | 8431641 | |
| Pubmed | 2.98e-06 | 87 | 158 | 6 | 20801516 | ||
| Pubmed | Cellular taxonomy of Hic1+ mesenchymal progenitor derivatives in the limb: from embryo to adult. | 3.18e-06 | 7 | 158 | 3 | 36008423 | |
| Pubmed | Genetic polymorphisms associated with priapism in sickle cell disease. | 5.07e-06 | 8 | 158 | 3 | 17408468 | |
| Pubmed | 7.57e-06 | 9 | 158 | 3 | 9256352 | ||
| Pubmed | 7.57e-06 | 9 | 158 | 3 | 9858722 | ||
| Pubmed | Severe defects in the formation of epaxial musculature in open brain (opb) mutant mouse embryos. | 7.57e-06 | 9 | 158 | 3 | 8565855 | |
| Pubmed | 8.91e-06 | 29 | 158 | 4 | 33298461 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | TNRC6B PUM2 DHX57 PATL1 ECT2 AKAP8L C2CD3 NYNRIN MIB1 ANKRD17 PSME3 | 9.43e-06 | 462 | 158 | 11 | 31138677 |
| Pubmed | Interplays of Gli2 and Gli3 and their requirement in mediating Shh-dependent sclerotome induction. | 1.08e-05 | 10 | 158 | 3 | 14602680 | |
| Pubmed | Pax2/5 and Pax6 subdivide the early neural tube into three domains. | 1.48e-05 | 11 | 158 | 3 | 10354469 | |
| Pubmed | Mitochondrial retention of Opa1 is required for mouse embryogenesis. | 1.48e-05 | 11 | 158 | 3 | 20652258 | |
| Pubmed | 1.96e-05 | 12 | 158 | 3 | 12435361 | ||
| Pubmed | Pax3 and Pax7 play essential safeguard functions against environmental stress-induced birth defects. | 1.96e-05 | 12 | 158 | 3 | 25800090 | |
| Pubmed | 1.96e-05 | 12 | 158 | 3 | 28625870 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 21357426 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 9016952 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 22423096 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 12833407 | ||
| Pubmed | Distinct functions between toll-like receptors 3 and 9 in retinal pigment epithelial cells. | 2.05e-05 | 2 | 158 | 2 | 17534115 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 35967300 | ||
| Pubmed | Global changes in gene expression and synergistic interactions induced by TLR9 and TLR3. | 2.05e-05 | 2 | 158 | 2 | 19535142 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 38520880 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 28093541 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 27346341 | ||
| Pubmed | Lysophospholipases cooperate to mediate lipid homeostasis and lysophospholipid signaling. | 2.05e-05 | 2 | 158 | 2 | 30482805 | |
| Pubmed | Evolutionary conservation of gene structures of the Pax1/9 gene family. | 2.05e-05 | 2 | 158 | 2 | 10899593 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 25388852 | ||
| Pubmed | Genomic variation in pancreatic ion channel genes in Japanese type 2 diabetic patients. | 2.05e-05 | 2 | 158 | 2 | 11424233 | |
| Pubmed | A transcription factor-based mechanism for mouse heterochromatin formation. | 2.05e-05 | 2 | 158 | 2 | 22983563 | |
| Pubmed | Costimulatory activation of murine invariant natural killer T cells by toll-like receptor agonists. | 2.05e-05 | 2 | 158 | 2 | 22795895 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 21132533 | ||
| Pubmed | Alternate PAX3 and PAX7 C-terminal isoforms in myogenic differentiation and sarcomagenesis. | 2.05e-05 | 2 | 158 | 2 | 21421465 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 29860675 | ||
| Pubmed | Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines. | 2.05e-05 | 2 | 158 | 2 | 21398612 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 27639618 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 11259252 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 8943322 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 17396232 | ||
| Pubmed | Pax3 and Pax7 have distinct and overlapping functions in adult muscle progenitor cells. | 2.05e-05 | 2 | 158 | 2 | 16380438 | |
| Pubmed | Genetic suppression of agrin reduces mania-like behavior in Na+ , K+ -ATPase α3 mutant mice. | 2.05e-05 | 2 | 158 | 2 | 22520507 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 17698736 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 22001237 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 37925639 | ||
| Pubmed | The role of Toll-like receptors 3 and 9 in the development of autoimmune diabetes in NOD mice. | 2.05e-05 | 2 | 158 | 2 | 19120284 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 26823795 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 16847112 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 12647804 | ||
| Pubmed | [TLR3c.1377, TLR9-1486, and TLR9 2848 gene polymorphisms and multiple sclerosis]. | 2.05e-05 | 2 | 158 | 2 | 20197609 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 28109979 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 24771867 | ||
| Pubmed | Sequence, expression in Escherichia coli, and characterization of lysophospholipase II. | 2.05e-05 | 2 | 158 | 2 | 10064901 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 32631940 | ||
| Pubmed | Expression of Toll‑like receptors 3 and 9 in Egyptian systemic lupus erythematosus patients. | 2.05e-05 | 2 | 158 | 2 | 26680366 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 16751377 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 25500505 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 10698202 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 18483407 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 26934656 | ||
| Pubmed | The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma. | 2.05e-05 | 2 | 158 | 2 | 23467704 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 7557998 | ||
| Pubmed | Comparison of the proximal promoter regions of the PAX3 and PAX7 genes. | 2.05e-05 | 2 | 158 | 2 | 17954266 | |
| Pubmed | Harmful Roles of TLR3 and TLR9 in Cardiac Dysfunction Developing during Polymicrobial Sepsis. | 2.05e-05 | 2 | 158 | 2 | 30364002 | |
| Pubmed | Protection against Ischemic Heart Disease: A Joint Role for eNOS and the KATP Channel. | 2.05e-05 | 2 | 158 | 2 | 37175633 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 8863157 | ||
| Pubmed | Regulation of osteoclastogenesis by integrated signals from toll-like receptors. | 2.05e-05 | 2 | 158 | 2 | 25079212 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 8167223 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 16630822 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 10662641 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 38461287 | ||
| Pubmed | The transmembrane domain directs TLR9 to intracellular compartments that contain TLR3. | 2.05e-05 | 2 | 158 | 2 | 16554027 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 26911613 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 19221588 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 32939755 | ||
| Pubmed | Enzymatic protein depalmitoylation by acyl protein thioesterases. | 2.05e-05 | 2 | 158 | 2 | 25849916 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 37532523 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 12408049 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 34906906 | ||
| Pubmed | Alterations in somite patterning of Myf-5-deficient mice: a possible role for FGF-4 and FGF-6. | 2.54e-05 | 13 | 158 | 3 | 8565825 | |
| Interaction | TOP3B interactions | ALKBH4 MAN2A2 INPPL1 THAP8 TNRC6B DHX57 RCC1 PATL1 MLLT10 REV3L FHIP1B KIFC2 EML3 AKAP8L FASN C2CD3 CELSR3 KCNJ11 MIB1 STRN4 ANKRD17 PCNX1 PAX2 BRAT1 DOCK6 MRPL11 AGRN EP300 | 4.67e-06 | 1470 | 152 | 28 | int:TOP3B |
| GeneFamily | Paired boxes | 2.44e-12 | 9 | 103 | 6 | 675 | |
| GeneFamily | Regulating synaptic membrane exocytosis family|PDZ domain containing | 1.91e-04 | 4 | 103 | 2 | 833 | |
| GeneFamily | Blood group antigens|CD molecules|Proteoglycans | 6.63e-04 | 7 | 103 | 2 | 570 | |
| GeneFamily | Alkylation repair homologs | 1.13e-03 | 9 | 103 | 2 | 401 | |
| GeneFamily | CD molecules|Toll like receptors | 1.40e-03 | 10 | 103 | 2 | 948 | |
| GeneFamily | Solute carriers | SLC39A11 SLC22A7 SLC4A1 SLC22A18 SLC9A5 SLCO1C1 SLC16A1 SLC26A11 | 1.89e-03 | 395 | 103 | 8 | 752 |
| GeneFamily | PRD class homeoboxes and pseudogenes | 1.89e-03 | 92 | 103 | 4 | 521 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.48e-07 | 186 | 158 | 8 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.48e-07 | 186 | 158 | 8 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.03e-07 | 200 | 158 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.88e-06 | 181 | 158 | 7 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-06 | 182 | 158 | 7 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-06 | 182 | 158 | 7 | b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.34e-06 | 190 | 158 | 7 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 5.92e-06 | 193 | 158 | 7 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 5.92e-06 | 193 | 158 | 7 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.12e-06 | 194 | 158 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.33e-06 | 195 | 158 | 7 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.55e-06 | 196 | 158 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.55e-06 | 196 | 158 | 7 | eea354bdaf4c558df6a94ec4f2f817f7073821d9 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.47e-06 | 200 | 158 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 151 | 158 | 6 | 5893a51585a65f1902cf85124a5ed9f02b4eb82a | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 151 | 158 | 6 | 771224e0d6fccfa4225b3adccd7bc22a89a40793 | |
| ToppCell | COVID-19-Heart-Adipocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.80e-05 | 153 | 158 | 6 | 93958bd9c951222ba5b740d1cb83fd5d78a10e1e | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-05 | 157 | 158 | 6 | 2b60de520edf167f5ca790b478557a778435b3d9 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-05 | 157 | 158 | 6 | 0ad242320ada7bcb9e29548d3050bf4fd3a07115 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-05 | 157 | 158 | 6 | fe4c9556806203e57522d1986754ebe5a20aa2de | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue-9|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.23e-05 | 159 | 158 | 6 | f376bf6cd0ed374211edac3c384f3a78f0caef2a | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 162 | 158 | 6 | 484ea4ac40de672dcbd2583a52cb7f385c918814 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 162 | 158 | 6 | bba144ac5332bab9eba2ccf599703c781a7f88f1 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.57e-05 | 163 | 158 | 6 | 218b9ba099cb27aa91c6b73bf89b44895f5dddc3 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 164 | 158 | 6 | 8e6dbddacd56a07769163813e3ebfad13302bb62 | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.75e-05 | 165 | 158 | 6 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | droplet-Heart-nan-18m-Hematologic-red_blood_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-05 | 101 | 158 | 5 | af4a84e4993d4e80c834e1591556b3b3781deaf3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Mesenchymal-Mes-Myofibroblast-VLMC_L1-3_CYP1B1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.25e-05 | 170 | 158 | 6 | 7d736e741799b67a7f022fc6766841c951ef8951 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Mesenchymal-Mes-Myofibroblast|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.25e-05 | 170 | 158 | 6 | 489fc97f6002a577b882a8ff3c563b1e42041d38 | |
| ToppCell | droplet-Heart-nan-18m-Hematologic-erythrocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 104 | 158 | 5 | 060f0baca239ab89c18be40c1aa31931f4791b62 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.C1ql2_(red_nucleus,_magnocellular/parvicellular_(RMC/RPC))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.34e-05 | 55 | 158 | 4 | 0e90e59184916d1c51b62c9b97498365173cb271 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.C1ql2_(red_nucleus,_magnocellular/parvicellular_(RMC/RPC))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.34e-05 | 55 | 158 | 4 | 9ea9e69d0f6cc4317df3538ee030a703e62c644f | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 182 | 158 | 6 | dc55de945c6f78f32eb3a1b3520835eb8417e068 | |
| ToppCell | B_cell_maturation-immature_B_cell|World / Lineage and Cell class | 4.76e-05 | 182 | 158 | 6 | 2c7c51ebc4125d8a33454ffee0b143579ce5e451 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.76e-05 | 182 | 158 | 6 | b4f347fb684f6840c166d7473f3f56389f69c14b | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 182 | 158 | 6 | 010a7364da46101cb5068891fd7bc712ea8f13bd | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-05 | 184 | 158 | 6 | 6388c47b7f1d8203e3069eba0e74107256dcae51 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.06e-05 | 184 | 158 | 6 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-05 | 184 | 158 | 6 | d83ae1dc64aa1b27d3b524c137567418cc0ff8c6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-05 | 184 | 158 | 6 | f6148e9591e8845cc62668e49fd52755257cdc7e | |
| ToppCell | B_cell_maturation-immature_B_cell|B_cell_maturation / Lineage and Cell class | 5.53e-05 | 187 | 158 | 6 | 9afbb21654c8eb6f9c6a7cbd0664d890282ddceb | |
| ToppCell | LPS_only-Unknown-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.64e-05 | 115 | 158 | 5 | ad5298c2ad8bf94fa13c2e50b0799e929473ef59 | |
| ToppCell | LPS_only-Unknown|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.64e-05 | 115 | 158 | 5 | 7a733f6987b40ec497a03734b79ed5355ad3a2fc | |
| ToppCell | LPS_only-Unknown-Endothelial-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.64e-05 | 115 | 158 | 5 | c67145d3cd9243994a141749b426ff2a6dcc8d93 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.70e-05 | 188 | 158 | 6 | 9fd262bbf6cdebfd945e39428a6059726fb55b3a | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.70e-05 | 188 | 158 | 6 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.70e-05 | 188 | 158 | 6 | 459e3fd4335a6f25f982d011b38702f4fcfed1cd | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.70e-05 | 188 | 158 | 6 | 0e2d1b21f0a7ee306e7dae16fc8c19d16a467883 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.87e-05 | 189 | 158 | 6 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.22e-05 | 191 | 158 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-pre-B-I_cell|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.22e-05 | 191 | 158 | 6 | 146edd214aac49f9b910bb982e3d77a052c8b316 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l11|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.37e-05 | 118 | 158 | 5 | a58dc4fcd92adcae5fae364052be4b909797e9f0 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.40e-05 | 192 | 158 | 6 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.40e-05 | 192 | 158 | 6 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.40e-05 | 192 | 158 | 6 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 194 | 158 | 6 | c9ebdcc2ea600975dade68a41fa65d1f8a5a5926 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.78e-05 | 194 | 158 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 194 | 158 | 6 | ad1aacff97beb76f4211942676e1d5e84087d44e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-05 | 194 | 158 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.78e-05 | 194 | 158 | 6 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 194 | 158 | 6 | fdd59b1e036b2d6d8877e1a920a0e56a91a2a882 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.18e-05 | 196 | 158 | 6 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.18e-05 | 121 | 158 | 5 | 05c40fd39e6b6275f35aaad835f95a81fcbb0990 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.38e-05 | 197 | 158 | 6 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tmem132c_(SN/VTA_(SNr))--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.42e-05 | 63 | 158 | 4 | e1b68ef6123ad084ce602b09fd1ba394785797e5 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tmem132c_(SN/VTA_(SNr))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.42e-05 | 63 | 158 | 4 | 9bfd9ba1335a155ed9e56dd41dd3621b37d4234e | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tmem132c_(SN/VTA_(SNr))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.42e-05 | 63 | 158 | 4 | 9a90c761898618fc7e5e2984baa1021b74d4ac39 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 7.59e-05 | 198 | 158 | 6 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.80e-05 | 199 | 158 | 6 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.80e-05 | 199 | 158 | 6 | f5c3561744e2a0e7716657cb521acb1d8f054b41 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 158 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.02e-05 | 200 | 158 | 6 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | proximal-3-Epithelial-Proximal_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.02e-05 | 200 | 158 | 6 | 3a0c84f9a551fc2581ec3693481eada297d83f7b | |
| ToppCell | proximal-Epithelial-Proximal_Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.02e-05 | 200 | 158 | 6 | de9aec87c86ad0a1bd5e0737c2aae0ec6f269bca | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.02e-05 | 200 | 158 | 6 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.02e-05 | 200 | 158 | 6 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.02e-05 | 200 | 158 | 6 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.02e-05 | 200 | 158 | 6 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.02e-05 | 200 | 158 | 6 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | proximal-Epithelial-Proximal_Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.02e-05 | 200 | 158 | 6 | ff2afa5c0352c214525129f9ff85afc139fe44d2 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.12e-04 | 70 | 158 | 4 | 8d6bdf2e773e894a0db39fdff1fafc2474e03fcf | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.12e-04 | 133 | 158 | 5 | d5326a6ccada5ae6d3e8f7d4a858c90050e23c5b | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.20e-04 | 135 | 158 | 5 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-matrix_-_mature_3|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.29e-04 | 137 | 158 | 5 | 9bfdbc102cdd861996b3c4eac35b606be8af97eb | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-DC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.33e-04 | 138 | 158 | 5 | 096c0c8ed396a27d29cca94e2e15099b64129c57 | |
| ToppCell | droplet-Liver-Npc-21m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 75 | 158 | 4 | 7f3be37cc378ee115fcb4b0eb9653fc77447aa0a | |
| ToppCell | P03-Hematopoietic|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.48e-04 | 141 | 158 | 5 | 4a856521520ea73291f4730fe94c5de88c2b6f0c | |
| ToppCell | LPS-IL1RA-Endothelial-Mes-Like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-04 | 145 | 158 | 5 | 90ca38c02325c5c637c32efdef634b54cc3cd105 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 148 | 158 | 5 | 7c7c87b57aa16f8b91698489df39ace5a3a53df8 | |
| ToppCell | P03-Hematopoietic-Immune-immune_cell_unspecified|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.91e-04 | 149 | 158 | 5 | 43d756f81d532b5c7f2306e6af9d072d496cbc8e | |
| ToppCell | P03-Hematopoietic-Immune|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.91e-04 | 149 | 158 | 5 | 1c5a2572741c47246d455c865e8e1677c9f49598 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-4|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.97e-04 | 150 | 158 | 5 | bcb99c6fa81052556ab30f9db5875fccf1ae724b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.03e-04 | 151 | 158 | 5 | 29d91a7d1470121af45fb8bb35175f2acced4551 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.03e-04 | 151 | 158 | 5 | 9ebfbdccc9656fce8990d06622f225009633f07c | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-04 | 153 | 158 | 5 | 82b77c8bae49dd63b8f10eb67df66ca71d0bb315 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_C-8|TCGA-Thymus / Sample_Type by Project: Shred V9 | 2.29e-04 | 155 | 158 | 5 | 00eef9f93a753a1fe1ab5fd8dae026e7be556cde | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-04 | 157 | 158 | 5 | bd45590da540a557dc8096980a45220fccb99505 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-04 | 157 | 158 | 5 | 00c9a58b033b8b95b0d838f233dd077b62d8b02a | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-3|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.58e-04 | 159 | 158 | 5 | fb222c42f66901852b01cec073ec0732245ee973 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 159 | 158 | 5 | 886cbaef39a3517514a3896b6b960d01a3af043d | |
| Drug | Gelsemine [509-15-9]; Down 200; 12.4uM; PC3; HT_HG-U133A | CACNB3 PIDD1 RCC1 FOXN3 MLLT10 NYNRIN FGF6 PCNX1 ATP1A3 DOCK6 | 1.04e-06 | 197 | 155 | 10 | 4097_DN |
| Disease | RHABDOMYOSARCOMA 2 | 7.78e-05 | 3 | 151 | 2 | 268220 | |
| Disease | alveolar rhabdomyosarcoma (is_implicated_in) | 7.78e-05 | 3 | 151 | 2 | DOID:4051 (is_implicated_in) | |
| Disease | Motor delay | 7.78e-05 | 3 | 151 | 2 | C1854301 | |
| Disease | Alveolar rhabdomyosarcoma | 7.78e-05 | 3 | 151 | 2 | cv:C0206655 | |
| Disease | sphingomyelin measurement | 9.75e-05 | 278 | 151 | 8 | EFO_0010118 | |
| Disease | insomnia measurement | GRIA1 GRIK3 MLLT10 CYP2W1 NTAN1 TMEM132E MED12L SDK1 KLHDC8B EP300 | 1.00e-04 | 443 | 151 | 10 | EFO_0007876 |
| Disease | esophagus adenocarcinoma (is_implicated_in) | 1.63e-04 | 21 | 151 | 3 | DOID:4914 (is_implicated_in) | |
| Disease | Alveolar rhabdomyosarcoma | 2.58e-04 | 5 | 151 | 2 | C0206655 | |
| Disease | Ischemic stroke | 2.77e-04 | 324 | 151 | 8 | HP_0002140 | |
| Disease | schizophrenia (implicated_via_orthology) | 4.16e-04 | 68 | 151 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | level of Sphingomyelin (d42:2) in blood serum | 4.35e-04 | 29 | 151 | 3 | OBA_2045183 | |
| Disease | level of Sphingomyelin (d38:1) in blood serum | 4.82e-04 | 30 | 151 | 3 | OBA_2045180 | |
| Disease | migraine disorder | 5.26e-04 | 357 | 151 | 8 | MONDO_0005277 | |
| Disease | level of Sphingomyelin (d40:1) in blood serum | 5.84e-04 | 32 | 151 | 3 | OBA_2045182 | |
| Disease | Liver Cirrhosis, Experimental | COL6A2 INPPL1 ITGAL IFI35 ECT2 IVD ACSL1 IGFALS C5AR1 C7 RNF39 NOS3 | 6.59e-04 | 774 | 151 | 12 | C0023893 |
| Disease | Familial hyperinsulinism | 7.14e-04 | 8 | 151 | 2 | cv:C3888018 | |
| Disease | lung disease (biomarker_via_orthology) | 7.62e-04 | 35 | 151 | 3 | DOID:850 (biomarker_via_orthology) | |
| Disease | Human papillomavirus infectious disease (is_marker_for) | 1.14e-03 | 10 | 151 | 2 | DOID:11166 (is_marker_for) | |
| Disease | Congenital neurologic anomalies | 1.14e-03 | 10 | 151 | 2 | C0497552 | |
| Disease | Cranioschisis | 1.14e-03 | 10 | 151 | 2 | C0265541 | |
| Disease | nephritis (implicated_via_orthology) | 1.14e-03 | 10 | 151 | 2 | DOID:10952 (implicated_via_orthology) | |
| Disease | level of Sphingomyelin (d34:0) in blood serum | 1.39e-03 | 11 | 151 | 2 | OBA_2045176 | |
| Disease | Mammary Carcinoma, Human | 1.59e-03 | 525 | 151 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.59e-03 | 525 | 151 | 9 | C1257931 | |
| Disease | Mammary Neoplasms | 1.63e-03 | 527 | 151 | 9 | C1458155 | |
| Disease | Clear Cell Meningioma | 1.66e-03 | 12 | 151 | 2 | C0431121 | |
| Disease | Intraventricular Meningioma | 1.66e-03 | 12 | 151 | 2 | C1334271 | |
| Disease | Benign Meningioma | 1.66e-03 | 12 | 151 | 2 | C0281784 | |
| Disease | Intraorbital Meningioma | 1.66e-03 | 12 | 151 | 2 | C1334261 | |
| Disease | Olfactory Groove Meningioma | 1.66e-03 | 12 | 151 | 2 | C1335107 | |
| Disease | Angioblastic Meningioma | 1.66e-03 | 12 | 151 | 2 | C1527197 | |
| Disease | Meningiomas, Multiple | 1.66e-03 | 12 | 151 | 2 | C0205834 | |
| Disease | Xanthomatous Meningioma | 1.66e-03 | 12 | 151 | 2 | C0457190 | |
| Disease | Angiomatous Meningioma | 1.66e-03 | 12 | 151 | 2 | C0334608 | |
| Disease | Psammomatous Meningioma | 1.66e-03 | 12 | 151 | 2 | C0334607 | |
| Disease | Fibrous Meningioma | 1.66e-03 | 12 | 151 | 2 | C0334606 | |
| Disease | Meningothelial meningioma | 1.66e-03 | 12 | 151 | 2 | C0334605 | |
| Disease | Hemangioblastic Meningioma | 1.66e-03 | 12 | 151 | 2 | C0334609 | |
| Disease | Transitional Meningioma | 1.66e-03 | 12 | 151 | 2 | C0334611 | |
| Disease | Hemangiopericytic Meningioma | 1.66e-03 | 12 | 151 | 2 | C0334610 | |
| Disease | Spinal Meningioma | 1.66e-03 | 12 | 151 | 2 | C0347515 | |
| Disease | Intracranial Meningioma | 1.66e-03 | 12 | 151 | 2 | C0349604 | |
| Disease | Papillary Meningioma | 1.66e-03 | 12 | 151 | 2 | C3163622 | |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 1.66e-03 | 12 | 151 | 2 | DOID:3319 (is_marker_for) | |
| Disease | Malignant Meningioma | 1.66e-03 | 12 | 151 | 2 | C0259785 | |
| Disease | Sphenoid Wing Meningioma | 1.66e-03 | 12 | 151 | 2 | C1565951 | |
| Disease | Posterior Fossa Meningioma | 1.66e-03 | 12 | 151 | 2 | C1565950 | |
| Disease | Parasagittal Meningioma | 1.66e-03 | 12 | 151 | 2 | C0751304 | |
| Disease | Cerebral Convexity Meningioma | 1.66e-03 | 12 | 151 | 2 | C0751303 | |
| Disease | Microcystic meningioma | 1.66e-03 | 12 | 151 | 2 | C1384408 | |
| Disease | Secretory meningioma | 1.66e-03 | 12 | 151 | 2 | C1384406 | |
| Disease | status epilepticus (biomarker_via_orthology) | 1.77e-03 | 100 | 151 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | Breast Carcinoma | 1.87e-03 | 538 | 151 | 9 | C0678222 | |
| Disease | Mental Depression | 2.02e-03 | 254 | 151 | 6 | C0011570 | |
| Disease | Heschl's gyrus morphology measurement | 2.55e-03 | 53 | 151 | 3 | EFO_0005852 | |
| Disease | acute lymphoblastic leukemia (is_implicated_in) | 2.84e-03 | 55 | 151 | 3 | DOID:9952 (is_implicated_in) | |
| Disease | 2-hydroxyglutarate measurement | 2.98e-03 | 16 | 151 | 2 | EFO_0021506 | |
| Disease | diabetic retinopathy (implicated_via_orthology) | 2.98e-03 | 16 | 151 | 2 | DOID:8947 (implicated_via_orthology) | |
| Disease | Endometrial Neoplasms | 3.30e-03 | 58 | 151 | 3 | C0014170 | |
| Disease | pre-eclampsia (biomarker_via_orthology) | 3.36e-03 | 17 | 151 | 2 | DOID:10591 (biomarker_via_orthology) | |
| Disease | Night blindness, congenital stationary | 3.36e-03 | 17 | 151 | 2 | C0339535 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 3.36e-03 | 17 | 151 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | Insulin Resistance | 3.63e-03 | 60 | 151 | 3 | C0021655 | |
| Disease | Insulin Sensitivity | 3.63e-03 | 60 | 151 | 3 | C0920563 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 3.77e-03 | 18 | 151 | 2 | EFO_1000649, HP_0000131 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 3.81e-03 | 61 | 151 | 3 | C1961102 | |
| Disease | Depressive disorder | 3.82e-03 | 289 | 151 | 6 | C0011581 | |
| Disease | glomerulonephritis (is_marker_for) | 4.20e-03 | 19 | 151 | 2 | DOID:2921 (is_marker_for) | |
| Disease | Meningioma | 4.20e-03 | 19 | 151 | 2 | C0025286 | |
| Disease | mean arterial pressure | 4.29e-03 | 499 | 151 | 8 | EFO_0006340 | |
| Disease | Deaf Mutism | 4.65e-03 | 20 | 151 | 2 | C4082305 | |
| Disease | maximal midexpiratory flow rate | 4.65e-03 | 20 | 151 | 2 | EFO_0004313 | |
| Disease | Deafness, Acquired | 4.65e-03 | 20 | 151 | 2 | C0751068 | |
| Disease | Hearing Loss, Extreme | 4.65e-03 | 20 | 151 | 2 | C0086395 | |
| Disease | Complete Hearing Loss | 4.65e-03 | 20 | 151 | 2 | C0581883 | |
| Disease | Bilateral Deafness | 4.65e-03 | 20 | 151 | 2 | C3665473 | |
| Disease | Prelingual Deafness | 4.65e-03 | 20 | 151 | 2 | C0011052 | |
| Disease | Disorder of eye | 4.79e-03 | 212 | 151 | 5 | C0015397 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EFGPGGRQQELGQEL | 276 | Q9NXW9 | |
| EIQVGLQPGQGEQLL | 406 | Q9H993 | |
| QIGQLPQALGAEAGA | 2241 | Q09472 | |
| QYLQQGELLPGLFGE | 91 | Q6PJG6 | |
| GQLNGIPQAGQAELF | 526 | Q96LX7 | |
| LLRAVFGRQAGGPVQ | 166 | A6NCS6 | |
| IPGLQNQQLLGERGE | 376 | P54284 | |
| PLQQTGQLFGGLVRD | 371 | P02730 | |
| GLGNGVSRNQLLPVL | 51 | Q96BT7 | |
| FQRGIQVSNNGPCLG | 96 | P33121 | |
| QRGGQEQPFLCLRGD | 331 | O95264 | |
| NVGIGFHLQVLPDGR | 91 | P10767 | |
| NNQRLELGIGPGAAT | 1526 | O00468 | |
| PIAIFQLIQRGGGIF | 101 | Q8TAV3 | |
| NGTGVQGGQIPELIF | 506 | Q9Y2F9 | |
| GFLNLQGGQLGSLEP | 101 | P35858 | |
| GLAVLGVFLQIGEPN | 141 | Q8N1Q1 | |
| GFTPQERQGFGELLQ | 231 | P27695 | |
| QGVIVGQPVLGQAQL | 981 | O75179 | |
| NPIIYVVAGQGFQGR | 296 | P21730 | |
| PVLSGQQGFQGLIGV | 681 | Q9UBL0 | |
| GALQRQIRGIPGLDV | 621 | Q9ULX6 | |
| VRLQEGRPEFGGLQL | 131 | Q8N4T4 | |
| QGQLGRVPELFANRG | 201 | P18754 | |
| NDTLGFNIIGGRPNQ | 231 | Q6ZMN7 | |
| VQRGLVQPGAVQRGL | 631 | Q9H0J4 | |
| VQRGLVQPGAVQRGL | 641 | Q9H0J4 | |
| VQRGLVQPGVDQRGL | 651 | Q9H0J4 | |
| DQRGLVQPGAVQRGL | 661 | Q9H0J4 | |
| QLFQVPLEEEGQRGG | 476 | Q9H8V3 | |
| GQQQVLRAGAGQRPL | 381 | Q8TB72 | |
| TPLGQGRVNQLGGVF | 31 | P23759 | |
| GRVNQLGGVFINGRP | 36 | P23759 | |
| NQLGGVFVNGRPLPD | 21 | Q02548 | |
| QAAQLVLQPGRDGAG | 876 | Q8N612 | |
| IGVIGGLGLAFNLNP | 116 | P53985 | |
| LQRAQLLGGAQLQPG | 261 | Q86TB9 | |
| GEVNQLGGVFVNGRP | 6 | P55771 | |
| GFQNQVRLAGGRIPE | 416 | Q96JB6 | |
| QALQQSPLVGGGIDA | 2016 | Q86YW9 | |
| GLQNGVPGLRLIQQE | 156 | Q9H9P8 | |
| LLLFGRPGRGQTQQE | 11 | Q8IV16 | |
| VDFQPLGFGVNGLVL | 21 | P31152 | |
| GFAEQLQEIIARLPG | 256 | Q8TDD1 | |
| GAERGNREPFLQALG | 241 | Q9NRD8 | |
| LGVRGNVLRFLPDQG | 76 | Q9NR23 | |
| ENGVGGNSIFLVAPL | 241 | Q14654 | |
| DILGGPISLGNIRNF | 2011 | Q96RV3 | |
| RLCQIGQFTVPLGGQ | 191 | P80217 | |
| VRGQGDLLQPGREFL | 1101 | Q6ZNL6 | |
| NIFQGVIGGDNIRLN | 626 | Q9H0H0 | |
| AQGVRQLGLELGRPV | 106 | P13942 | |
| VNGYPVGGQNDLERL | 516 | Q86UT5 | |
| GLQGAQDRGFPVSLQ | 506 | P16050 | |
| FIRGEGVGAYNPQLN | 536 | Q9UL01 | |
| NQAPGVGDCLRQQLG | 186 | Q96CW5 | |
| QLGNLGVLGITAPVQ | 86 | P26440 | |
| AGSFPEIQGFLQLRG | 226 | Q14451 | |
| PQGAEVAAGLLQRQG | 346 | P48741 | |
| QTNPLVRLGAGGAFE | 626 | Q9Y2H9 | |
| NQLGGVFVNGRPLPD | 21 | Q02962 | |
| RNPGGLQIGDLVNID | 241 | Q86YT6 | |
| VRLDTGGQEGLQYQP | 781 | P29474 | |
| IGLIPHDQGNFVNGI | 376 | Q86YD1 | |
| TPLGQGRVNQLGGVF | 31 | P23760 | |
| GRVNQLGGVFINGRP | 36 | P23760 | |
| GNLIFPGVRLGADSQ | 1501 | Q86UR5 | |
| LLQQEQQGLAGPLGD | 11 | Q0D2I5 | |
| GLNGLPQLGYQAAVL | 516 | P06401 | |
| EVNQLGGVFVNGRPL | 101 | P15863 | |
| EGPLGVINNFRLGRL | 261 | A8MW95 | |
| GYNLRPGLDNQTLGV | 351 | Q9H3Q3 | |
| ALEQGRGDPIYLGIQ | 66 | Q9NZH8 | |
| LVNNLPDIGGRNIGV | 121 | Q5DX21 | |
| QPRNIGLIAGAIGTG | 236 | Q5DX21 | |
| LDGLPIGRVQINGLA | 121 | Q4AC94 | |
| PIISGQIVNLGRGAF | 791 | Q96HP0 | |
| ARGQQGPNLAIGRQK | 6 | P57796 | |
| LSNQGLPIGLQFIGR | 466 | Q9H0R6 | |
| ELRGNLTGAPGQRLQ | 101 | O60883 | |
| VLFGGGQVNVQLQRG | 1306 | Q6P158 | |
| IQNGARVLSRGLFPG | 276 | O00409 | |
| REQLGALLGPGQQFL | 181 | H7C350 | |
| RVALLQFGGPGEQQV | 876 | P12110 | |
| TQNNVLRGEPFIRGG | 366 | P10643 | |
| FLRQSQQQLGLGIPG | 166 | Q6ZR85 | |
| CQFALGGRGQKPELQ | 116 | P49641 | |
| NGIPSNRIILGGFSQ | 106 | O75608 | |
| IPANRIVLGGFSQGG | 111 | O95372 | |
| VILAENGFLPGNLVG | 861 | P13637 | |
| PQGAFQGLGELQVLA | 331 | P40197 | |
| LSGRVIVAGGLGNQP | 276 | Q8IYD2 | |
| QAGPRLFVIGGVAQG | 326 | Q8IXV7 | |
| QTPIGRNLGRNDIVG | 131 | Q86TM3 | |
| AQLPAQGRRLGNGVQ | 136 | P08246 | |
| LRGDLAQGFSPVIQG | 581 | Q32P44 | |
| GQAVLQLGIEGAPQA | 316 | Q14289 | |
| LGGLLPAQFQAERRG | 2416 | Q9NYQ7 | |
| LIRAELGQPGNLLGN | 36 | P00395 | |
| VVGANFPNNIQIGGL | 16 | P42261 | |
| QLALGVVAIFGPSQG | 101 | Q13003 | |
| QLGPVGGVFNLAVVL | 1961 | P49327 | |
| EQLARAFVGGGPQLL | 121 | Q9BPU9 | |
| RVGGNIEVLGFNARQ | 1406 | Q14839 | |
| LLEQVGGFGPFQLRN | 6 | Q9Y694 | |
| GGFGPFQLRNVALLA | 11 | Q9Y694 | |
| GGLQIAPVFIQDAGN | 536 | Q7Z5N4 | |
| RNLAIGIGIQNFPEG | 231 | Q8N1S5 | |
| GIGIQNFPEGLAVSL | 236 | Q8N1S5 | |
| QAPGQIGGVVGLNLY | 1526 | Q8TDX9 | |
| LLNGNVRPRANGDVG | 2106 | Q01668 | |
| RLAVRQGPEGQGGIQ | 546 | Q96AC6 | |
| ERQAGQPGAVGLLVQ | 841 | Q9HB75 | |
| LNLSGEPGNQGLRRV | 781 | Q9P2P1 | |
| NGRDINGQLIFVGRA | 251 | P0CB38 | |
| GPVLGQRGVSINQFC | 36 | Q9Y3B7 | |
| AQQAQTGLGPVLGAL | 166 | Q8NA92 | |
| PHQGAFRAGNVIGQL | 16 | Q8N8V8 | |
| IFGVENEPTLNLGNG | 156 | Q8N6T0 | |
| GGRLAGEGQLQNIPI | 876 | Q8N3T6 | |
| VFLGNGQPLRVQGEL | 936 | Q6IEE7 | |
| VFNQVIGPGGLLQGT | 791 | O95255 | |
| DFLDGLGPAQIVGRQ | 136 | Q9UJD0 | |
| GRNLGQTNEGLIPVR | 731 | Q5VVP1 | |
| PQGNGTVAGFELLLQ | 211 | O60861 | |
| GGLVREPFGRDQLSQ | 176 | Q6ZV89 | |
| DQRGLQAVGVGIFPN | 186 | Q8NB12 | |
| QAVGVGIFPNLGLVN | 191 | Q8NB12 | |
| GLLPGGKAREFNRNQ | 41 | Q5VSL9 | |
| GELIGLYAQPNQGLV | 96 | O15357 | |
| GLQQAGLVAPRVQAG | 156 | Q14940 | |
| PNVLANVGAAGQVLR | 136 | Q9BR26 | |
| RIPQGFGNLLEGLTR | 11 | Q15506 | |
| LQGRPGFQECIKGNV | 141 | P20701 | |
| AGGQPLAIQLRAELG | 201 | A8MXQ7 | |
| RLLRGQSVQQVGPQG | 31 | Q96AB6 | |
| ERAPGQGTNGFQLLR | 41 | Q08648 | |
| LGGINRNEGPLVYIQ | 36 | Q6ZWJ1 | |
| FGLVNNAGVAGIIGP | 106 | Q92781 | |
| IGLEGAQAPLGIQLR | 426 | A0A1B0GV85 | |
| RVRPTFQGNGLNGEL | 271 | P57078 | |
| LQLLGGPVFGRFADQ | 71 | Q96BI1 | |
| ALPGNQLAINGIVGA | 901 | P55197 | |
| GQQQYGPGTVLLGLE | 166 | Q9NQ32 | |
| QLLIPRIEDGNNFGV | 141 | P61289 | |
| PGLVGLRALGLLQQQ | 86 | Q6ZTK2 | |
| GAQGQPRGLQLEGEL | 421 | Q6ZTK2 | |
| GRLFGLFLNNVQLGP | 221 | O15455 | |
| AGVRGTAQQPRLFVG | 116 | P27449 | |
| LNGLVYIGQRGDNIP | 71 | Q5JS37 | |
| LNRLDIEAQIGGNPG | 246 | O60673 | |
| IDNIGAGVIQPGRGF | 51 | P62487 | |
| GFGQIKNLLGLQNIP | 166 | Q86WA9 | |
| QALEVAPGALLGLGN | 186 | Q9NR96 | |
| LAFGQGRGPILLDNV | 111 | Q8WTU2 | |
| FLGNLLRGIGETPIQ | 191 | Q9NYB5 | |
| GRLPGTVAGQQFLIQ | 51 | O75695 | |
| TGVAAQGNILGLFPQ | 66 | Q16559 | |
| LGPQAVGGRQDRALQ | 146 | I3L0S3 | |
| QGALLGAAQRPQAGD | 351 | Q6ZMY9 | |
| RLGGSVLGQIPFLQN | 256 | Q9NRL3 | |
| IGFGLRLPQGQARAL | 296 | Q53SZ7 | |
| ERAPGQGTNGFQLLR | 41 | Q6PDA7 | |
| LLRDVQLSGPGGQAQ | 36 | Q92748 | |
| AEVLQGLGGGFRQPL | 211 | Q9BXU2 | |
| VLNLRTAGQGPGQLQ | 66 | Q03167 | |
| IGTGLNPQNFAARQG | 1181 | Q9UPQ9 | |
| KGLNQEPQGRGLALQ | 256 | Q49AM3 | |
| RFDQLPAVLGAQGFG | 266 | Q9H2S5 | |
| ILSGNQLGRIAPGAF | 126 | Q6PJG9 | |
| RILAPGFIDVQINGG | 61 | Q9Y303 |